1. Home
  2. TIL vs CLAR Comparison

TIL vs CLAR Comparison

Compare TIL & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • CLAR
  • Stock Information
  • Founded
  • TIL 2018
  • CLAR 1957
  • Country
  • TIL United States
  • CLAR United States
  • Employees
  • TIL N/A
  • CLAR N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • CLAR Recreational Games/Products/Toys
  • Sector
  • TIL Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • TIL 171.7M
  • CLAR 150.4M
  • IPO Year
  • TIL 2021
  • CLAR N/A
  • Fundamental
  • Price
  • TIL $26.95
  • CLAR $3.18
  • Analyst Decision
  • TIL Buy
  • CLAR Strong Buy
  • Analyst Count
  • TIL 5
  • CLAR 4
  • Target Price
  • TIL $119.00
  • CLAR $5.50
  • AVG Volume (30 Days)
  • TIL 316.4K
  • CLAR 161.6K
  • Earning Date
  • TIL 05-13-2025
  • CLAR 05-08-2025
  • Dividend Yield
  • TIL N/A
  • CLAR 3.13%
  • EPS Growth
  • TIL N/A
  • CLAR N/A
  • EPS
  • TIL N/A
  • CLAR N/A
  • Revenue
  • TIL N/A
  • CLAR $255,437,000.00
  • Revenue This Year
  • TIL N/A
  • CLAR N/A
  • Revenue Next Year
  • TIL N/A
  • CLAR $6.30
  • P/E Ratio
  • TIL N/A
  • CLAR N/A
  • Revenue Growth
  • TIL N/A
  • CLAR N/A
  • 52 Week Low
  • TIL $9.62
  • CLAR $3.02
  • 52 Week High
  • TIL $92.00
  • CLAR $7.13
  • Technical
  • Relative Strength Index (RSI)
  • TIL 65.08
  • CLAR 44.52
  • Support Level
  • TIL $12.60
  • CLAR $3.05
  • Resistance Level
  • TIL $35.28
  • CLAR $3.18
  • Average True Range (ATR)
  • TIL 3.84
  • CLAR 0.14
  • MACD
  • TIL 1.60
  • CLAR 0.01
  • Stochastic Oscillator
  • TIL 63.27
  • CLAR 31.37

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: